Cartalax (20mg Vial)

01 · At a glance

Quickstart Highlights

Cartalax (Ala‑Glu‑Asp; “AED”) is described in the scholarly literature as an ultrashort, cartilage‑associated peptide motif that can influence fibroblast activity and extracellular‑matrix regulation in vitro. [1] [2] [3] Ultrashort peptides are known to utilize peptide transporters (e.g., POT/LAT families) and demonstrate cell‑penetrating and gene‑expression effects in model systems. [4] [3] This educational framework presents a once‑daily subcutaneous measurement schedule using a practical dilution for clear insulin‑syringe readings (see evidence notes and technique references below).

02 · Dosing & reconstitution

Dosing & Reconstitution Guide

A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.

Standard / Gradual Approach (3.0 mL = ~6.67 mg/mL)

(measurement framework): 2,000–5,000 mcg once daily (gradual titration for syringe readability; see volume tolerability notes [7] [8] ).

Reconstitution Steps

1. Using aseptic technique, draw 3.0 mL bacteriostatic water with a sterile syringe.
2. Insert the needle through the stopper and let the diluent run slowly down the vial wall; avoid foaming.
3. Gently swirl/roll until fully dissolved (do not shake).
4. Maintain sterility per best‑practice guidance. [6] [10] Label the vial and handle with standard precautions; avoid repeated freeze–thaw and protect from light exposure when practical. [10] Evidence note: Published human posology specific to Cartalax (AED) is limited; the once‑daily SC framework above prioritizes measurement clarity and SC tolerability whi...

03 · What you'll need

Supplies Needed

Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.

Protocol Overview

• Goal: Provide clear syringe math while reflecting literature that AED/Cartalax‑related motifs can modulate fibroblast activity and matrix‑related signaling in models. [1] [2] [3]
• Schedule: Daily subcutaneous measurements for 8–12 weeks (optional extension to 16 weeks) with gradual titration. Dose Range (framework): 2–5 mg daily with stepwise increases to maintain comfortable SC volumes. [7] [8]
• Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for straightforward unit conversions.

Dosing Protocol

• Suggested stepwise increases for syringe readability; follow recognized SC administration technique.
• Start: 2.0–3.0 mg daily; increase by ~0.5–1.0 mg every 1–2 weeks as needed for unit clarity.
• Target: 4.0–5.0 mg daily by Weeks 5–12 (≤0.75 mL per SC site at this dilution).
• Frequency: Once per day (subcutaneous).
• Timing: Use a consistent daily time; rotate sites.
• Evidence note: Route/volume guidance references focus on safe SC technique and tolerability; specific Cartalax RCT posology is limited in the published record. [5] [7] [8]

Storage Instructions

• Review the source instructions and storage notes before handling any vial.
• Keep mixed and unmixed items clearly labeled so inventory and dose logs stay accurate.

04 · Good to know

Important Notes

• This Cartalax page is for educational research organization only.
• Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
• Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.

05 · How it works

How This Works

Cartalax (Ala‑Glu‑Asp; “AED”) is described in the scholarly literature as an ultrashort, cartilage‑associated peptide motif that can influence fibroblast activity and extracellular‑matrix regulation in vitro. [1] [2] [3] Ultrashort peptides are known to utilize peptide transporters (e.g., POT/LAT families) and demonstrate cell‑penetrating and gene‑express...

Reconstitute: Add 3.0 mL bacteriostatic water per 20 mg vial → ~ 6.67 mg/mL concentration.

Example daily range (measurement framework): 2,000–5,000 mcg once daily (gradual titration for syringe readability; see volume tolerability notes [7] [8] ).

The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.

06 · Daily habits

Lifestyle Factors

• Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
• Track body metrics only if they are relevant to the user's goal and approved data sources.
• Use consistent timing and logging habits so adherence data is meaningful.

07 · What to expect

Potential Benefits & Side Effects

• Cartalax observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
• This section is not a claim of therapeutic benefit.

08 · Technique

Injection Technique

09 · Evidence

References